Search for Clinical Trial Results

Sponsored By

Leiomyosarcoma - 26 Studies Found

Status Study
Recruiting Study Name: Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas
Condition: Leiomyosarcoma
Date: 2011-08-10
Interventions: Drug: pazopanib + gemcitabine pazopanib tablets (200mg) per os, 800mg/day continuously gemcitabine IV, 2
Active, not recruiting Study Name: Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
Condition: Leiomyosarcoma
Date: 2014-09-23
Interventions:
  • Drug: gemcitabine + docetaxel

Completed Study Name: Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Condition: Leiomyosarcoma
Date: 2009-03-04
Interventions: Drug: letrozole Taken orally once a day continuously
Withdrawn Study Name: Pazopanib for Treating Uterine Leiomyosarcoma
Condition: Uterine Leiomyosarcoma
Date: 2015-02-17
Interventions: Drug: Pazopanib
Active, not recruiting Study Name: SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Condition: Metastatic Leiomyosarcoma
Date: 2014-11-21
Interventions:
  • Drug: Mocetinostat
  • Drug: Gemcitabine
Suspended Study Name: Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Condition: Uterine Corpus Leiomyosarcoma
Date: 2015-04-23
Interventions:
  • Biological: Ipilimumab Given I
Completed Study Name: Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma
Condition:
  • Uterus Leiomyosarcoma
  • Soft Tissue Leiomyo
    Date: 2014-05-05
    Interventions:
    • Drug: Doxorubicin 60 mg/m²
Recruiting Study Name: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Condition:
  • Liposarcoma
  • Leiomyosarcoma

Date: 2014-09-05
Interventions: Drug: Trabectedin Trabectedin administered at a dose of 1.5 mg/m2 - 1.3 mg/m2 (at investigator's discret
Not yet recruiting Study Name: Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
Condition: Uterine or Soft Tissue Leiomyosarcoma
Date: 2016-12-13
Interventions:
  • Drug: Doxorubicin
  • Drug: Trabectedin
Completed Study Name: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Condition: Advanced Liposarcoma or Leiomyosarcoma
Date: 2011-04-26
Interventions:
  • Drug: Trabectedin Type=exactly
Next >>>